"Phase I trial of TAS-102 and concurrent radiation therapy for patients with locally recurrent, unresectable or metastatic, rectal cancer."

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

TPS3623Background: After primary therapy for rectal cancer (chemotherapy, surgery, and/or radiotherapy), 7-10% of patients will develop locally recurrent disease. Re-irradiation +/- resection of re... Click to show full abstract

Keywords: therapy; locally recurrent; rectal cancer; phase trial

Journal Title: Journal of Clinical Oncology
Year Published: 2018

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
0

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended